What is Generate Biomedicines, Inc. 's shares (basic)?

Generate Biomedicines, Inc. (GENB) reported shares (basic) of 64.9M in Q1 2026.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Generate Biomedicines, Inc. GENB Shares (Basic)

Shares (Basic) at other companies

MYR GroupMYRG

15.5M-2.8%

Piper SandlerPIPR

67.8M+3.6%

SSR MiningSSRM

205.6M+1.6%

RepligenRGEN

56.4M+0.4%

NNN REITNNN

189M+1.2%

American Healthcare REITAHR

187.3M+19.4%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's shares (basic)?: Generate Biomedicines, Inc. (GENB) reported shares (basic) of 64.9M in Q1 2026.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.